SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques
Authors
Keywords
-
Journal
Science Advances
Volume 8, Issue 11, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-03-17
DOI
10.1126/sciadv.abl6015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
- (2021) Yin-Feng Kang et al. ACS Nano
- A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
- (2021) Tiong Kit Tan et al. Nature Communications
- Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
- (2021) Yunjiao Zhou et al. Cell Reports
- The antigenic anatomy of SARS-CoV-2 receptor binding domain
- (2021) Wanwisa Dejnirattisai et al. CELL
- SARS-CoV-2 Vaccines
- (2021) C. Buddy Creech et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
- (2021) J Peter Figueroa et al. LANCET
- Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
- (2021) Peter Richmond et al. LANCET
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report
- (2021) Kai Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
- (2021) Francisco J. Salguero et al. Nature Communications
- Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
- (2021) Hyon-Xhi Tan et al. Nature Communications
- Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays
- (2021) Jingyou Yu et al. JOURNAL OF VIROLOGY
- India’s massive COVID surge puzzles scientists
- (2021) Smriti Mallapaty NATURE
- Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
- (2021) Prabhu S. Arunachalam et al. NATURE
- COVID-19 dynamics after a national immunization program in Israel
- (2021) Hagai Rossman et al. NATURE MEDICINE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines
- (2021) Yury Valdes-Balbin et al. ACS Central Science
- In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
- (2021) Dapeng Li et al. CELL
- Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
- (2021) Neil C. Dalvie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered Komagataella phaffii
- (2021) Neil C. Dalvie et al. BIOTECHNOLOGY AND BIOENGINEERING
- Immunogenicity of a BNT162b2 vaccine booster in health-care workers
- (2021) Esther Saiag et al. Lancet Microbe
- Responding to Covid-19 — A Once-in-a-Century Pandemic?
- (2020) Bill Gates NEW ENGLAND JOURNAL OF MEDICINE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
- (2020) Lianpan Dai et al. CELL
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
- (2020) Jingyun Yang et al. NATURE
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- Developing a low-cost and accessible COVID-19 vaccine for global health
- (2020) Peter J. Hotez et al. PLoS Neglected Tropical Diseases
- NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
- (2020) Mimi Guebre-Xabier et al. VACCINE
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- The influence of domestic manufacturing capabilities on biologic pricing in emerging economies
- (2019) Anurag S. Rathore et al. NATURE BIOTECHNOLOGY
- A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response
- (2019) Arianna Marini et al. Frontiers in Immunology
- Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
- (2018) Stephanie F. James et al. ANNALS OF PHARMACOTHERAPY
- The yeast stands alone: the future of protein biologic production
- (2018) Kerry R Love et al. CURRENT OPINION IN BIOTECHNOLOGY
- Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display
- (2017) Susheel K. Singh et al. VACCINE
- Pichia Power: India's Biotech Industry Puts Unconventional Yeast to Work
- (2008) Chandra Shekhar CHEMISTRY & BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started